全文获取类型
收费全文 | 7997篇 |
免费 | 659篇 |
国内免费 | 27篇 |
专业分类
耳鼻咽喉 | 115篇 |
儿科学 | 336篇 |
妇产科学 | 275篇 |
基础医学 | 1118篇 |
口腔科学 | 144篇 |
临床医学 | 972篇 |
内科学 | 1403篇 |
皮肤病学 | 145篇 |
神经病学 | 784篇 |
特种医学 | 202篇 |
外科学 | 765篇 |
综合类 | 68篇 |
一般理论 | 12篇 |
预防医学 | 902篇 |
眼科学 | 170篇 |
药学 | 510篇 |
中国医学 | 33篇 |
肿瘤学 | 729篇 |
出版年
2023年 | 58篇 |
2022年 | 94篇 |
2021年 | 212篇 |
2020年 | 166篇 |
2019年 | 211篇 |
2018年 | 186篇 |
2017年 | 149篇 |
2016年 | 199篇 |
2015年 | 195篇 |
2014年 | 306篇 |
2013年 | 394篇 |
2012年 | 612篇 |
2011年 | 585篇 |
2010年 | 345篇 |
2009年 | 338篇 |
2008年 | 536篇 |
2007年 | 520篇 |
2006年 | 498篇 |
2005年 | 464篇 |
2004年 | 472篇 |
2003年 | 464篇 |
2002年 | 402篇 |
2001年 | 79篇 |
2000年 | 49篇 |
1999年 | 76篇 |
1998年 | 98篇 |
1997年 | 83篇 |
1996年 | 58篇 |
1995年 | 60篇 |
1994年 | 62篇 |
1993年 | 64篇 |
1992年 | 45篇 |
1991年 | 38篇 |
1990年 | 41篇 |
1989年 | 36篇 |
1988年 | 30篇 |
1987年 | 30篇 |
1986年 | 23篇 |
1985年 | 38篇 |
1984年 | 40篇 |
1983年 | 26篇 |
1982年 | 31篇 |
1981年 | 32篇 |
1978年 | 18篇 |
1977年 | 13篇 |
1975年 | 16篇 |
1973年 | 21篇 |
1972年 | 21篇 |
1970年 | 14篇 |
1969年 | 14篇 |
排序方式: 共有8683条查询结果,搜索用时 15 毫秒
121.
Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy. 总被引:1,自引:0,他引:1
Emanuel F Petricoin Verena E Bichsel Valerie S Calvert Virginia Espina Mary Winters Lynn Young Claudio Belluco Bruce J Trock Marc Lippman David A Fishman Dennis C Sgroi Peter J Munson Laura J Esserman Lance A Liotta 《Journal of clinical oncology》2005,23(15):3614-3621
Mapping tumor cell protein networks in vivo will be critical for realizing the promise of patient-tailored molecular therapy. Cancer can be defined as a dysregulation or hyperactivity in the network of intracellular and extracellular signaling cascades. These protein signaling circuits are the ultimate targets of molecular therapy. Each patient's tumor may be driven by a distinct series of molecular pathogenic defects. Thus, for any single molecular targeted therapy, only a subset of cancer patients may respond. Individualization of therapy, which tailors a therapeutic regimen to a tumor molecular portrait, may be the solution to this dilemma. Until recently, the field lacked the technology for molecular profiling at the genomic and proteomic level. Emerging proteomic technology, used concomitantly with genomic analysis, promises to meet this need and bring to reality the clinical adoption of molecular stratification. The activation state of kinase-driven signal networks contains important information relative to cancer pathogenesis and therapeutic target selection. Proteomic technology offers a means to quantify the state of kinase pathways, and provides post-translational phosphorylation data not obtainable by gene arrays. Case studies using clinical research specimens are provided to show the feasibility of generating the critical information needed to individualize therapy. Such technology can reveal potential new pathway interconnections, including differences between primary and metastatic lesions. We provide a vision for individualized combinatorial therapy based on proteomic mapping of phosphorylation end points in clinical tissue material. 相似文献
122.
Abeer M Shaaban Valerie Speirs 《Clinical cancer research》2005,11(22):8222; author reply 8222-8222; author reply 8223
123.
Sudhir Tauro Charles Craddock Karl Peggs Gulnaz Begum Premini Mahendra Gordon Cook Judith Marsh Donald Milligan Anthony Goldstone Ann Hunter Asim Khwaja Raj Chopra Timothy Littlewood Andrew Peniket Anne Parker Graham Jackson Geoff Hale Mark Cook Nigel Russell Stephen Mackinnon 《Journal of clinical oncology》2005,23(36):9387-9393
PURPOSE: The toxicity of allogeneic stem-cell transplantation can be substantially reduced using a reduced-intensity conditioning (RIC) regimen. This has increased the proportion of patients with myeloid malignancies eligible for allogeneic transplantation. However, the capacity of RIC allografts to produce durable remissions in patients with acute myeloid leukemia (AML) and myelodysplasia (MDS) has not yet been defined, and consequently, the role of RIC allografts in the management of these diseases remains conjectural. PATIENTS AND METHODS: Seventy-six patients with high-risk AML or MDS received an allograft using a fludarabine/melphalan RIC regimen incorporating alemtuzumab. The median age of the cohort was 52 years (range, 18 to 71 years). RESULTS: The 100-day transplantation-related mortality rate was 9%, and no patient developed greater than grade 2 graft-versus-host disease. With a median follow-up of 36 months (range, 13 to 70 months), 27 patients were alive and in remission, with 3-year actuarial overall survival (OS) and disease-free survival (DFS) rates of 41% and 37%, respectively. The 3-year OS and DFS rates of patients with AML in complete remission at the time of transplantation were 48% and 42%, respectively. Disease relapse was the most common cause of treatment failure and occurred at a median time of 6 months after transplantation. All but one patient destined to relapse did so within 24 months of transplantation. CONCLUSION: The extended follow-up in this series identifies a high risk of early disease relapse but provides evidence that RIC allografts can produce sustained DFS in a significant number of patients with AML who would be ineligible for allogeneic transplantation with myeloablative conditioning. 相似文献
124.
125.
Emily Banks Gillian Reeves Valerie Beral Diana Bull Barbara Crossley Moya Simmonds Elizabeth Hilton Stephen Bailey Nigel Barrett Peter Briers Ruth English Alan Jackson Elizabeth Kutt Janet Lavelle Linda Rockall Matthew G Wallis Mary Wilson Julietta Patnick 《British medical journal》2004,328(7451):1291-1292
126.
Janna M. Wisniewski Valerie A. Yeager Mark L. Diana David R. Hotchkiss 《The International journal of health planning and management》2016,31(4):e302-e311
The number of health systems strengthening (HSS) programs has increased in the last decade. However, a limited number of studies providing robust evidence for the value and impact of these programs are available. This study aims to identify knowledge gaps and challenges that impede rigorous monitoring and evaluation (M&E) of HSS, and to ascertain the extent to which these efforts are informed by existing technical guidance. Interviews were conducted with HSS advisors at United States Agency for International Development‐funded missions as well as senior M&E advisors at implementing partner and multilateral organizations. Findings showed that mission staff do not use existing technical resources, either because they do not know about them or do not find them useful. Barriers to rigorous M&E included a lack suitable of indicators, data limitations, difficulty in demonstrating an impact on health, and insufficient funding and resources. Consensus and collaboration between international health partners and local governments may mitigate these challenges. Copyright © 2016 John Wiley & Sons, Ltd. 相似文献
127.
Using action research to develop midwives’ skills to support women with perinatal mental health needs 下载免费PDF全文
128.
This case-control study adds to the growing body of knowledge on the medical, nutritional, and environmental factors associated with Nodding Syndrome (NS), a seizure disorder of children and adolescents in northern Uganda. Past research described a significant association between NS and prior history of measles infection, dependence on emergency food and, at head nodding onset, subsistence on moldy maize, which has the potential to harbor mycotoxins. We used LC-MS/MS to screen for current mycotoxin loads by evaluating nine analytes in urine samples from age-and-gender matched NS cases (n = 50) and Community Controls (CC, n = 50). The presence of the three mycotoxins identified in the screening was not significantly different between the two groups, so samples were combined to generate an overall view of exposure in this community during the study. Compared against subsequently run standards, α-zearalenol (43 ± 103 µg/L in 15 samples > limit of quantitation (LOQ); 0 (0/359) µg/L), T-2 toxin (39 ± 81 µg/L in 72 samples > LOQ; 0 (0/425) µg/L) and aflatoxin M1 (4 ± 10 µg/L in 15 samples > LOQ; 0 (0/45) µg/L) were detected and calculated as the average concentration ± SD; median (min/max). Ninety-five percent of the samples had at least one urinary mycotoxin; 87% were positive for two of the three compounds detected. While mycotoxin loads at NS onset years ago are and will remain unknown, this study showed that children with and without NS currently harbor foodborne mycotoxins, including those associated with maize. 相似文献
129.
130.
Emily Polander Valerie L. Shalin 《International journal of mental health and addiction》2013,11(4):458-473
This study examined lay individuals’ use of narrative and figurative language for communicating biomedical and psychosocial concepts in online alcoholism discussion forums. We performed quantitative and qualitative analyses of content, narrative, and figurative language on 311 opening forum posts. Linguistic patterns indicated a distinction between narrative and figurative functions of language in communication that is sensitive to the concreteness of the content. Individuals were more likely to use narrative to convey concrete psychosocial content, and figurative language to convey abstract psychosocial content. Individuals did not use narrative or figurative language to communicate abstract, technical biomedical content. Although they belong to the biomedical model, concrete physical symptoms receive treatment in a manner more similar to concrete psychosocial content than more abstract, technical biomedical content. Our findings suggest that individuals’ use of narrative and figurative language is largely driven by the concreteness or perceptibility of the underlying content rather than the content domain. 相似文献